Yun Zhong
Stock Analyst at Wedbush
(0.17)
# 4,560
Out of 4,673 analysts
434
Total ratings
43.5%
Success rate
-5.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $94 | $66.70 | +40.93% | 18 | Aug 18, 2026 | |
| CAMP Camp4 Therapeutics | Rated: Buy | $8 | $4.48 | +78.57% | 9 | Aug 14, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $327 | $253.29 | +29.10% | 31 | Aug 13, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Buy | $16 → $15 | $3.51 | +327.35% | 23 | Aug 11, 2026 | |
| KLRS Kalaris Therapeutics | Rated: Buy | $17 | $4.15 | +309.64% | 4 | Aug 11, 2026 | |
| SGMT Sagimet Biosciences | Maintained: Buy | $28 | $10.25 | +173.17% | 12 | Aug 11, 2026 | |
| PTGX Protagonist Therapeutics | Rated: Buy | $118 → $173 | $154.32 | +12.10% | 29 | Aug 10, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $34 | $15.76 | +115.74% | 22 | Aug 10, 2026 | |
| VYGR Voyager Therapeutics | Maintained: Buy | $8 | $3.39 | +135.99% | 25 | Aug 7, 2026 | |
| MNKD MannKind | Maintained: Buy | $8 | $4.15 | +92.77% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.05 | +146.91% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $18.79 | +86.27% | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $11.03 | +45.06% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $12 | $5.29 | +126.84% | 21 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $13.48 | +18.69% | 1 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $5 → $6 | $5.09 | +17.88% | 23 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 | $4.44 | +80.18% | 24 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $3.24 | n/a | 15 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.09 | n/a | 14 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 | $48.37 | n/a | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $37.63 | n/a | 13 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $10.04 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.2904 | n/a | 9 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.68 | n/a | 7 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $111.10 | n/a | 9 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.39 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $20.98 | n/a | 2 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $24.92 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.16 | n/a | 3 | Jun 28, 2018 |
BioMarin Pharmaceutical
Aug 18, 2026
Maintained: Buy
Price Target: $94
Current: $66.70
Upside: +40.93%
Camp4 Therapeutics
Aug 14, 2026
Rated: Buy
Price Target: $8
Current: $4.48
Upside: +78.57%
Ascendis Pharma
Aug 13, 2026
Maintained: Buy
Price Target: $327
Current: $253.29
Upside: +29.10%
Rocket Pharmaceuticals
Aug 11, 2026
Rated: Buy
Price Target: $16 → $15
Current: $3.51
Upside: +327.35%
Kalaris Therapeutics
Aug 11, 2026
Rated: Buy
Price Target: $17
Current: $4.15
Upside: +309.64%
Sagimet Biosciences
Aug 11, 2026
Maintained: Buy
Price Target: $28
Current: $10.25
Upside: +173.17%
Protagonist Therapeutics
Aug 10, 2026
Rated: Buy
Price Target: $118 → $173
Current: $154.32
Upside: +12.10%
MoonLake Immunotherapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $34
Current: $15.76
Upside: +115.74%
Voyager Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $8
Current: $3.39
Upside: +135.99%
MannKind
Aug 6, 2026
Maintained: Buy
Price Target: $8
Current: $4.15
Upside: +92.77%
Aug 6, 2026
Maintained: Buy
Price Target: $10
Current: $4.05
Upside: +146.91%
Aug 6, 2026
Reiterated: Buy
Price Target: $35
Current: $18.79
Upside: +86.27%
Aug 4, 2026
Maintained: Hold
Price Target: $16
Current: $11.03
Upside: +45.06%
Jul 31, 2026
Rated: Buy
Price Target: $15 → $12
Current: $5.29
Upside: +126.84%
Jul 28, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $13.48
Upside: +18.69%
Jun 3, 2026
Rated: Buy
Price Target: $5 → $6
Current: $5.09
Upside: +17.88%
Apr 21, 2026
Downgraded: Hold
Price Target: $8
Current: $4.44
Upside: +80.18%
Mar 30, 2023
Rated: Buy
Price Target: $28
Current: $3.24
Upside: n/a
Mar 30, 2023
Maintained: Hold
Price Target: n/a
Current: $6.09
Upside: n/a
Mar 28, 2023
Rated: Buy
Price Target: $38
Current: $48.37
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $4
Current: $37.63
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $8
Current: $10.04
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $4
Current: $0.2904
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.68
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $111.10
Upside: n/a
May 12, 2020
Reiterated: Buy
Price Target: $10
Current: $1.39
Upside: n/a
Feb 4, 2020
Reiterated: Buy
Price Target: $14
Current: $20.98
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $24.92
Upside: n/a
Jun 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $13.16
Upside: n/a